查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590656

纤维蛋白胶市场：按产品、最终用户划分 - 2025-2030 年全球预测

Fibrin Sealant Market by Product (Liquid Form, Patch), End-User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年纤维蛋白胶市值为3.9116亿美元，预计2024年将达到4.4589亿美元，复合年增长率为14.08%，到2030年将达到9.8402亿美元。

纤维蛋白胶主要由纤维蛋白原和凝血酶组成，用作止血剂以控制出血并在外科手术过程中帮助密封组织。纤维蛋白胶用于多种医学专业，包括心血管、整形外科和神经外科，以促进创伤治疗并减少术后併发症。当缝合或烧灼等传统止血方法不足时，这些密封剂至关重要，并且它们的应用在复杂的手术中至关重要。最终用途范围从医院和门诊手术中心到专科诊所。推动纤维蛋白胶市场成长要素包括全球手术数量的增加、手术技术的进步以及对需要有效控制出血的微创手术的需求不断增加。此外，人们越来越重视降低手术相关风险，从而增加了对有效止血剂的需求。这个市场开拓机会在于开发具有更高蛋白质纯度和生物相容性的具有成本效益的密封剂，以满足成熟市场和新兴市场的需求。此外，根据特定手术需求量身定制的配方以及创新给药系统（例如喷雾剂和新的施用器设计）的开发，为增长提供了潜在的途径。然而，局限性仍然存在，主要是由于纤维蛋白胶的高成本以及潜在的副作用和週期性免疫抗原性原性反应。除了血浆来源成分带来病毒感染的风险外，各地区严格的监管情况也是一个问题。为了促进成长，对开发合成或重组纤维蛋白产品的研究进行投资是有前途的，特别是旨在减少对捐赠者衍生产品的依赖的研究投资可以降低病毒风险。市场竞争激烈，但创新的时机已经成熟，生物技术公司和外科团队之间的持续研究和合作对于推动新开发和扩大市场开拓至关重要。

主要市场统计
基准年[2023] 3.9116 亿美元
预测年份 [2024] 44589万美元
预测年份 [2030] 98402万美元
复合年增长率（%） 14.08%

市场动态：揭示快速发展的纤维蛋白胶市场的关键市场洞察

纤维蛋白胶市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 越来越多地使用显微外科手术和植入部位周围的皮瓣闭合
    • 用于牙周手术的替代生医材料，可刺激牙周创伤治疗和再生
    • 牙科手术需求不断增长
  • 市场限制因素
    • 纤维蛋白胶高成本
  • 市场机会
    • 增加政府预算并提高医疗保健质量
    • 技术进步以适应外科手术的增加
  • 市场挑战
    • 过敏反应的征兆

波特的五力：驾驭纤维蛋白胶市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解纤维蛋白胶市场的外部影响

外部宏观环境因素在塑造纤维蛋白胶市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解纤维蛋白胶市场的竞争格局

对纤维蛋白胶市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵纤维蛋白胶市场供应商绩效评估

FPNV 定位矩阵是评估纤维蛋白胶市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了纤维蛋白胶市场的成功之路

纤维蛋白胶市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 越来越多地用于显微外科果冻和植入部位周围的皮瓣闭合
      • 用于牙周手术的替代生物材料，可促进牙周创伤治疗和再生
      • 牙科手术需求增加
    • 抑制因素
      • 纤维蛋白胶高成本
    • 机会
      • 增加政府资助并提高医疗品质
      • 技术进步可适应越来越多的外科手术
    • 任务
      • 过敏反应的征兆
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章纤维蛋白胶市场：副产品

  • 液体形式
  • 修补

第七章纤维蛋白胶市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第八章北美和南美纤维蛋白胶市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区纤维蛋白胶市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲纤维蛋白胶市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Baxter International Inc.
  • Cryolife Inc.
  • CSL Behring
  • Ethicon LLC
  • Haemcure Corporation
  • Harvest Technologies Inc.
  • Hualan Biological Engineering Inc.
  • Johnson & Johnson Services, inc
  • Mallinckrodt Pharmaceuticals
  • Medicines Company
  • Omrix Biopharmaceutical Inc.
  • Shanghai Raas Blood Products Co. Ltd
  • The Takeda Pharmaceutical Company Limited
  • Vivostat A/S
  • Zimmer Biomet
Product Code: MRR-4348D129FB3E

The Fibrin Sealant Market was valued at USD 391.16 million in 2023, expected to reach USD 445.89 million in 2024, and is projected to grow at a CAGR of 14.08%, to USD 984.02 million by 2030.

Fibrin sealants, composed mainly of fibrinogen and thrombin, serve as hemostatic agents used to control bleeding and aid tissue sealing during surgical procedures. The scope of fibrin sealant usage extends across a variety of medical departments, including cardiovascular, orthopedic, and neurosurgical applications, enhancing wound healing and reducing postoperative complications. These sealants are crucial where conventional methods of hemostasis, such as sutures or cauterization, are insufficient, making their application indispensable in complex surgeries. The end-use scope is broad, ranging from hospitals and ambulatory surgical centers to specialized clinics. Growth factors driving the fibrin sealant market include the increasing incidence of surgeries worldwide, advancements in surgical techniques, and the growing demand for minimally invasive procedures that require effective bleeding control. There's also a rising emphasis on reducing surgery-associated risks, propelling the demand for effective hemostatic agents. Opportunities in this market lie in the development of cost-effective sealants with enhanced protein purity and biocompatibility, catering to both established and emerging markets. Additionally, tailored formulations for specific surgical needs, and the deployment of innovative delivery systems, such as sprays or new applicator designs, offer potential growth avenues. However, limitations persist, primarily due to the high costs of fibrin sealants and the potential for side effects or periodical immunogenic reactions. Stringent regulatory landscapes across different regions also pose challenges, alongside the risk of viral transmission from plasma-derived components. To foster growth, investing in research that focuses on developing synthetic or recombinant fibrin formulations can be promising, particularly those aiming at reducing dependence on donor-derived products, which can mitigate viral risks. The nature of the market is competitive yet ripe for innovation, with continuous research and collaboration among biotech firms and surgical teams pivotal in driving forward novel developments and expanding market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 391.16 million
Estimated Year [2024] USD 445.89 million
Forecast Year [2030] USD 984.02 million
CAGR (%) 14.08%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fibrin Sealant Market

The Fibrin Sealant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use in microsurgical procedures and closing flaps around implant site
    • Alternative biomaterial for periodontal surgery stimulating periodontal wound healing and regeneration
    • Growing demand for dental surgeries
  • Market Restraints
    • High cost of fibrin sealants
  • Market Opportunities
    • Increase in government funding and improvement in the quality of healthcare
    • Advancements in technology to meet increasing surgical procedures
  • Market Challenges
    • Signs of an allergic reaction

Porter's Five Forces: A Strategic Tool for Navigating the Fibrin Sealant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fibrin Sealant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fibrin Sealant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fibrin Sealant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fibrin Sealant Market

A detailed market share analysis in the Fibrin Sealant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fibrin Sealant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fibrin Sealant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fibrin Sealant Market

A strategic analysis of the Fibrin Sealant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fibrin Sealant Market, highlighting leading vendors and their innovative profiles. These include Baxter International Inc., Cryolife Inc., CSL Behring, Ethicon LLC, Haemcure Corporation, Harvest Technologies Inc., Hualan Biological Engineering Inc., Johnson & Johnson Services, inc, Mallinckrodt Pharmaceuticals, Medicines Company, Omrix Biopharmaceutical Inc., Shanghai Raas Blood Products Co. Ltd, The Takeda Pharmaceutical Company Limited, Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Fibrin Sealant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Liquid Form and Patch.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use in microsurgical procedures and closing flaps around implant site
      • 5.1.1.2. Alternative biomaterial for periodontal surgery stimulating periodontal wound healing and regeneration
      • 5.1.1.3. Growing demand for dental surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of fibrin sealants
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in government funding and improvement in the quality of healthcare
      • 5.1.3.2. Advancements in technology to meet increasing surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Signs of an allergic reaction
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fibrin Sealant Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Form
  • 6.3. Patch

7. Fibrin Sealant Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Fibrin Sealant Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fibrin Sealant Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fibrin Sealant Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Baxter International Inc.
  • 2. Cryolife Inc.
  • 3. CSL Behring
  • 4. Ethicon LLC
  • 5. Haemcure Corporation
  • 6. Harvest Technologies Inc.
  • 7. Hualan Biological Engineering Inc.
  • 8. Johnson & Johnson Services, inc
  • 9. Mallinckrodt Pharmaceuticals
  • 10. Medicines Company
  • 11. Omrix Biopharmaceutical Inc.
  • 12. Shanghai Raas Blood Products Co. Ltd
  • 13. The Takeda Pharmaceutical Company Limited
  • 14. Vivostat A/S
  • 15. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. FIBRIN SEALANT MARKET RESEARCH PROCESS
  • FIGURE 2. FIBRIN SEALANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FIBRIN SEALANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FIBRIN SEALANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FIBRIN SEALANT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FIBRIN SEALANT MARKET DYNAMICS
  • TABLE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FIBRIN SEALANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FIBRIN SEALANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FIBRIN SEALANT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, 2023